Sökning: onr:"swepub:oai:gup.ub.gu.se/338386" > The efficacy of imm...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06836naa a2201021 4500 | |
001 | oai:gup.ub.gu.se/338386 | |
003 | SwePub | |
008 | 240608s2022 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:150361679 | |
009 | oai:prod.swepub.kib.ki.se:150961293 | |
009 | oai:gup.ub.gu.se/322093 | |
024 | 7 | a https://gup.ub.gu.se/publication/3383862 URI |
024 | 7 | a https://doi.org/10.1016/j.ejca.2022.03.0412 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1503616792 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1509612932 URI |
024 | 7 | a https://gup.ub.gu.se/publication/3220932 URI |
040 | a (SwePub)gud (SwePub)kid (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Holmberg, Carl Jacobu Gothenburg University,Göteborgs universitet,Sahlgrenska Centrum för Cancerforskning (SCCR),Wallenberg Centre for Molecular and Translational Medicine,Sahlgrenska Center for Cancer Research (SCCR),Institutionen för kliniska vetenskaper, Avdelningen för kirurgi,Institute of Clinical Sciences, Department of Surgery4 aut0 (Swepub:gu)xhocas |
245 | 1 0 | a The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study |
264 | 1 | b Elsevier BV,c 2022 |
520 | a Purpose: Guidelines addressing melanoma in-transit metastasis (ITM) recommend immune checkpoint inhibitors (ICI) as a first-line treatment option, despite the fact that there are no efficacy data available from prospective trials for exclusively ITM disease. The study aims to analyze the outcome of patients with ITM treated with ICI based on data from a large cohort of patients treated at international referral clinics. Methods: A multicenter retrospective cohort study of patients treated between January 2015 and December 2020 from Australia, Europe, and the USA, evaluating treatment with ICI for ITM with or without nodal involvement (AJCC8 N1c, N2c, and N3c) and without distant disease (M0). Treatment was with PD-1 inhibitor (nivolumab or pembrolizumab) and/or CTLA-4 inhibitor (ipilimumab). The response was evaluated according to the RECIST criteria modified for cutaneous lesions. Results: A total of 287 patients from 21 institutions in eight countries were included. Immunotherapy was first-line treatment in 64 (22%) patients. PD-1 or CTLA-4 inhibitor monotherapy was given in 233 (81%) and 23 (8%) patients, respectively, while 31 (11%) received both in combination. The overall response rate was 56%, complete response (CR) rate was 36%, and progressive disease (PD) rate was 32%. Median PFS was ten months (95% CI 7.4-12.6 months) with a one-, two-, and five-year PFS rate of 48%, 33%, and 18%, respectively. Median MSS was not reached, and the one-, two-, and five-year MSS rates were 95%, 83%, and 71%, respectively. Conclusion: Systemic immunotherapy is an effective treatment for melanoma ITM. Future studies should evaluate the role of systemic immunotherapy in the context of multimodality therapy, including locoregional treatments such as surgery, intralesional therapy, and regional therapies. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Melanoma | |
653 | a In-transit metastasis | |
653 | a Immune checkpoint inhibitor | |
653 | a PD-1 | |
653 | a Nivolumab | |
653 | a Pembrolizumab | |
653 | a Ipilimumab | |
653 | a Oncology | |
700 | 1 | a Ny, Lars,d 1967u Gothenburg University,Göteborgs universitet,Sahlgrenska Centrum för Cancerforskning (SCCR),Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Sahlgrenska Center for Cancer Research (SCCR),Institute of Clinical Sciences, Department of Oncology4 aut0 (Swepub:gu)xnylai |
700 | 1 | a Hieken, Tina J.4 aut |
700 | 1 | a Block, Matthew S.4 aut |
700 | 1 | a Carr, Michael J.4 aut |
700 | 1 | a Sondak, Vernon K.4 aut |
700 | 1 | a Ortenwall, Christoffer4 aut |
700 | 1 | a Katsarelias, Dimitriosu Gothenburg University,Göteborgs universitet,Sahlgrenska Centrum för Cancerforskning (SCCR),Sahlgrenska Center for Cancer Research (SCCR)4 aut0 (Swepub:gu)xkatdi |
700 | 1 | a Dimitriou, Florentia4 aut |
700 | 1 | a Menzies, Alexander M.4 aut |
700 | 1 | a Saw, Robyn P. M.4 aut |
700 | 1 | a Rogiers, Aljosja4 aut |
700 | 1 | a Straker, Richard J.4 aut |
700 | 1 | a Karakousis, Giorgos4 aut |
700 | 1 | a Applewaite, Rona4 aut |
700 | 1 | a Pallan, Lalit4 aut |
700 | 1 | a Han, Dale4 aut |
700 | 1 | a Vetto, John T.4 aut |
700 | 1 | a Gyorki, David E.4 aut |
700 | 1 | a Tie, Emilia Nan4 aut |
700 | 1 | a Vitale, Maria Grazia4 aut |
700 | 1 | a Ascierto, Paulo A.4 aut |
700 | 1 | a Dummer, Reinhard4 aut |
700 | 1 | a Cohen, Jade4 aut |
700 | 1 | a Hui, Jane Y. C.4 aut |
700 | 1 | a Schachter, Jacob4 aut |
700 | 1 | a Asher, Nethanel4 aut |
700 | 1 | a Helgadottir, H.u Karolinska Institutet4 aut |
700 | 1 | a Chai, Harvey4 aut |
700 | 1 | a Kroon, Hidde4 aut |
700 | 1 | a Coventry, Brendon4 aut |
700 | 1 | a Rothermel, Luke D.4 aut |
700 | 1 | a Sun, James4 aut |
700 | 1 | a Carlino, Matteo S.4 aut |
700 | 1 | a Duncan, Zoey4 aut |
700 | 1 | a Broman, Kristy4 aut |
700 | 1 | a Weber, Jeffrey4 aut |
700 | 1 | a Lee, Ann Y.4 aut |
700 | 1 | a Berman, Russell S.4 aut |
700 | 1 | a Teras, Juri4 aut |
700 | 1 | a Ollila, David W.4 aut |
700 | 1 | a Long, Georgina4 aut |
700 | 1 | a Zager, Jonathan S.4 aut |
700 | 1 | a van Akkooi, Alexander4 aut |
700 | 1 | a Olofsson Bagge, Roger,d 1978u Gothenburg University,Göteborgs universitet,Sahlgrenska Centrum för Cancerforskning (SCCR),Wallenberg Centre for Molecular and Translational Medicine,Sahlgrenska Center for Cancer Research (SCCR),Institutionen för kliniska vetenskaper, Avdelningen för kirurgi,Institute of Clinical Sciences, Department of Surgery4 aut0 (Swepub:gu)xoloro |
700 | 1 | a I. TforIT Res Collaboration, I. TforIT Res Collaboration4 aut |
710 | 2 | a Göteborgs universitetb Sahlgrenska Centrum för Cancerforskning (SCCR)4 org |
773 | 0 | t EUROPEAN JOURNAL OF CANCERd : Elsevier BVg 40:16q 169<210-222x 0959-8049x 1879-0852 |
773 | 0 | t JOURNAL OF CLINICAL ONCOLOGYd : Elsevier BVg 40:16q 40:16x 0732-183Xx 1527-7755 |
856 | 4 8 | u https://gup.ub.gu.se/publication/338386 |
856 | 4 8 | u https://doi.org/10.1016/j.ejca.2022.03.041 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:150361679 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:150961293 |
856 | 4 8 | u https://gup.ub.gu.se/publication/322093 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.